NCT07522268

Brief Summary

Diode lasers could be a viable alternative to ferric sulphate in pulpotomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jun 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
5.2 years until next milestone

First Submitted

Initial submission to the registry

March 27, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 13, 2026

Completed
Last Updated

April 14, 2026

Status Verified

April 1, 2026

Enrollment Period

1.6 years

First QC Date

March 27, 2026

Last Update Submit

April 9, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Presence of Pain or tenderness or mobility

    Teeth will be scored as clinical success if they had absence of pain, tenderness, pathological mobility, and sinus or abscess formation. Presence of any of these signs and symptoms will be scored as clinical failure.

    1,3,6,9, and 12 months intervals

  • Presence of resorption or periapical pathology

    Radiographic assessment included evaluation of pathological external or internal root resorption, periapical or inter-radicular radiolucency and widening of the periodontal ligament (PDL). Presence of any of these signs on the periapical radiograph will be recorded as a radiographic failure.

    1,3,6,9 and 12 months interval

Study Arms (2)

Group A (Ferric Sulphate)

ACTIVE COMPARATOR

Group A (Ferric Sulphate)

Combination Product: (Ferric Sulphate)

(Diode Laser)

EXPERIMENTAL

A diode laser (Fona, Germany) with a surgical fiber optic tip of 0.4-0.5mm diameter was used and pulp was ablated till the level of the canal orifice. Settings of laser were of wavelength between 810-980nm, set at 3W power in continuous wave/pulse mode for not more than 2-3 seconds. The operator, assistant and the patient were wearing protective eye wear during this procedure. Afterwards MTA (Cerkamed, Poland) was placed in 1mm thickness over the amputated pulp.

Procedure: Group B (Diode Laser)

Interventions

Group B (Diode Laser)

(Diode Laser)
(Ferric Sulphate)COMBINATION_PRODUCT

After hemostasis was achieved a sterile cotton pellet soaked in 15.5% ferric sulphate solution (Quickstat-FS, USA) was placed over amputated root stumps for 15-20 seconds.

Group A (Ferric Sulphate)

Eligibility Criteria

Age4 Years - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Primary molars( either mandibular or maxillary or both) of children in the age range of 4 to 8 years.
  • Absence of spontaneous pain, associated swelling, tenderness to percussion, pathological mobility, sinus tract

You may not qualify if:

  • Periapical Abscess
  • Necrotic pulp
  • Teeth nearing exfoliation
  • Non cooperative patients
  • Patients with poor oral hygiene
  • Parents/patients not willing to be a part of study
  • Any drug allergies
  • Any medical history contraindicating the pulp treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shaheed Zulfiqar Ali Bhutto Medical University

Islamabad, 44000, Pakistan

Location

MeSH Terms

Interventions

Lasers, Semiconductor

Intervention Hierarchy (Ancestors)

LasersOptical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor (Clinical)

Study Record Dates

First Submitted

March 27, 2026

First Posted

April 13, 2026

Study Start

June 1, 2019

Primary Completion

January 1, 2021

Study Completion

January 1, 2021

Last Updated

April 14, 2026

Record last verified: 2026-04

Locations